Table 1 Characteristics of included studies selected for meta-analysis.

From: Associations between polymorphisms of the ADIPOQ gene and hypertension risk: a systematic and meta-analysis

Study

Year

Country

Ethnicity

Age, mean ± SD, year

Body mass index (kg/m2)

Type of study

Sample size

Control source

Genotype distributions in cases/controls

Genotyping method

Quality score

HWE*

Case

Control

Case

Control

Case

Control

11

12

22

rs2241766

Machado GH

2014

Brazil

Caucasian

26 ± 4.5

24 ± 4

27.53 ± 5.15

22.80 ± 2.7

Case-control

113

169

HB

81/139

29/29

3/1

PCR

8

0.697

Machado PE

2014

Brazil

Caucasian

27 ± 4.5

24 ± 5

26.28 ± 4.8

22.80 ± 2.7

Case-control

127

169

HB

97/139

26/29

4/1

PCR

8

0.697

Jiang HT

2014

China

Mongolian

68.8 ± 6.7

67.1 ± 7.1

24.5 ± 4.3

23.1 ± 3.3

Case-control

202

166

PB

102/91

86/65

14/10

PCR

10

0.720

Jiang HT + DM

2014

China

Mongolian

68.2 ± 6.1

67.1 ± 7.2

26.0 ± 3.7

23.1 ± 3.3

Case-control

169

166

PB

90/91

67/65

12/10

PCR

10

0.720

Kang

2013

China

Mongolian

NA

NA

22.57 ± 2.27

21.53 ± 2.17

Case-control

153

126

HB

63/75

68/40

22/11

PCR

8

0.105

Leu HT

2011

China

Mongolian

41.4 ± 0.7

46.7 ± 0.8

25.4 ± 0.3

23.5 ± 0.1

Family-based

159

446

PB

74/233

70/181

15/32

PCR

10

0.696

Leu HT + Mets

2011

China

Mongolian

41.7 ± 0.6

57.5 ± 1.0

28.3 ± 0.3

27.1 ± 0.3

Family-based

192

165

PB

92/78

81/75

19/12

PCR

9

0.696

Youpeng

2010

China

Mongolian

30.9 ± 6.0

30.0 ± 4.5

22.05 ± 2.65

20.1 ± 1.8

Case-control

107

81

HB

74/53

26/27

7/1

PCR

7

0.228

Wang

2008

China

Mongolian

46.4 ± 14.0

46.8 ± 15.4

26.82 ± 2.44

22.43 ± 3.99

Case-control

80

160

HB

41/87

34/60

5/13

PCR

8

0.561

Tang

2008

China

Mongolian

63.5 ± 6.5

60.5 ± 7.1

NA

NA

Case-control

151

100

HB

99/63

32/28

20/9

PCR

8

0.036

Jeng

2007

China

Mongolian

51.6 ± 14.7

50.7 ± 12.1

25.7 ± 3.6

23.8 ± 3.4

Case-control

212

356

HB

82/126

99/173

31/57

PCR

9

0.853

Yan

2006

China

Mongolian

49 ± 9

48 ± 10

30.8 ± 2.5

22.4 ± 1.8

Case-control

482

497

HB

201/222

186/203

95/72

PCR

9

0.024

rs1501299

Machado GH

2014

Brazil

Caucasian

26 ± 4.5

24 ± 4

27.53 ± 5.15

22.80 ± 2.7

Case-control

113

161

HB

59/68

46/74

8/19

PCR

8

0.868

Machado PE

2014

Brazil

Caucasian

27 ± 4.5

24 ± 5

26.28 ± 4.8

22.80 ± 2.7

Case-control

127

161

HB

66/68

47/74

14/19

PCR

8

0.868

Kang

2013

China

Mongolian

NA

NA

22.57 ± 2.27

21.53 ± 2.17

Case-control

153

126

HB

100/82

46/38

7/6

PCR

8

0.560

Leu HT

2011

China

Mongolian

41.4 ± 0.7

46.7 ± 0.8

25.4 ± 0.3

23.5 ± 0.1

Family-based

159

446

PB

85/228

60/178

14/40

PCR

9

0.536

Leu HT + Mets

2011

China

Mongolian

41.7 ± 0.6

57.5 ± 1.0

28.3 ± 0.3

27.1 ± 0.3

Family-based

192

165

PB

117/93

68/56

7/16

PCR

9

0.089

Youpeng

2010

China

Mongolian

30.9 ± 6.0

30.0 ± 4.5

22.05 ± 2.65

20.1 ± 1.8

Case-control

107

81

HB

19/19

60/49

28/13

PCR

7

0.051

Wang

2008

China

Mongolian

46.4 ± 14.0

46.8 ± 15.4

26.82 ± 2.44

22.43 ± 3.99

Case-control

80

160

HB

41/74

28/73

11/13

PCR

8

0.392

Yan

2006

China

Mongolian

49 ± 9

48 ± 10

30.8 ± 2.5

22.4 ± 1.8

Case-control

482

497

HB

259/274

184/187

39/36

PCR

9

0.599

Iwashima

2004

Japan

Mongolian

59.4 ± 0.5

57.1 ± 0.6

24.4 ± 0.1

23.1 ± 0.2

Case-control

446

312

HB

225/165

180/124

41/23

PCR

9

0.964

rs266729

Machado GH

2014

Brazil

Caucasian

26 ± 4.5

24 ± 4

27.53 ± 5.15

22.80 ± 2.7

Case-control

113

161

HB

61/93

36/57

16/11

PCR

8

0.577

Machado PE

2014

Brazil

Caucasian

27 ± 4.5

24 ± 5

26.28 ± 4.8

22.80 ± 2.7

Case-control

127

161

HB

81/93

27/57

19/11

PCR

8

0.577

Leu HT

2011

China

Mongolian

41.4 ± 0.7

46.7 ± 0.8

25.4 ± 0.3

23.5 ± 0.1

Family-based

198

159

PB

85/84

90/64

23/11

PCR

9

0.800

Leu HT + Mets

2011

China

Mongolian

41.7 ± 0.6

57.5 ± 1.0

28.3 ± 0.3

27.1 ± 0.3

Family-based

173

159

PB

93/84

68/64

12/11

PCR

9

0.800

Zhang

2010

China

Mongolian

52.39 ± 9.60

49.25 ± 10.84

NA

NA

Case-control

220

268

HB

138/163

70/84

12/21

PCR

8

0.035

  1. For rs2241766 variant, 11, 12 and 22 represent TT, GT, GG, respectively; for rs1501299 variant, 11, 12 and 22 represent GG, TG and TT, respectively; for rs266729 variant, 11, 12 and 22 represent CC, CG, and GG.
  2. GH = gestational hypertension; PE = pre-eclampsia; HT = hypertension; DM = type 2 diabetes; Mets = metabolic syndrome; HB = hospital based; PB = population based; NA = not available.
  3. *P value for Hardy–Weinberg equilibrium test in controls.